美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物科技指數ETF-iShares Nasdaq

202.99

+0.99000.49%

成交量：23.98萬

成交額：4,860.42萬

市值：103.42億

市盈率：32.16

高：204.16

開：202.49

低：202.07

收：202.00

52周最高：217.12

52周最低：138.79

股本：5,095.00萬

流通股本：5,095.00萬

量比：0.63

換手率：0.47%

股息：0.40

股息率：0.20%

每股收益(TTM):6.31

每股收益(LYR):35.34

淨資產收益率：24.54%

總資產收益率：0.10%

市淨率：1.27

市盈率(LYR):5.74

資料載入中...

總覽公司新聞資訊公告

安進-阿斯利康肺癌聯合用藥在後期臨床試驗中顯著提升生存率

市場風向標：安進股價遭受重創

Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費

Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段

Assembly Biosciences：吉利德獨享HSV HPI項目臨床開發與商業化權利

Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權

安進股價或創二十餘年來最大單日跌幅

福泰製藥(VRTX)股票9月8日盤中下跌3.06%：投資者必看的核心信息

TradingKey中文

吉利德科學(GILD)股票9月8日盤中下跌3.26%：釋放什麼信號？

TradingKey中文

諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌

安進(AMGN)股票9月8日盤中下跌8.33%：真相來了

TradingKey中文

BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華

更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期

安進股價下跌7%，創下自2025年6月以來最大單日跌幅。

更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標

安進Phase 3 Dellphi-305研究重大突破：總生存期獲益顯著優於度伐利尤單抗單藥治療

Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善

BMO下調安進及BioNTech評級至「與大市同步」

美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾

老虎资讯综合

諾華試驗受挫且BMO下調評級，安進股價下跌

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/IBB/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":202.99,"timestamp":1789570596027,"preClose":202,"halted":0,"volume":239807,"delay":0,"changeRate":0.004900990099009946,"floatShares":50950000,"shares":50950000,"eps":6.311863,"marketStatus":"交易中","change":0.99,"latestTime":"09-16 10:56:38 EDT","open":202.49,"high":204.1599,"low":202.07,"amount":48604164.29438,"amplitude":0.010346,"askPrice":203.06,"askSize":16,"bidPrice":202.98,"bidSize":84,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202,"sharesOutstanding":49450000,"nav":204.610559,"aum":10516982732.6,"dividendRate":0.00199,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":203.71,"preClose":202,"latestTime":"09:17 EDT","volume":108,"amount":21996.522,"timestamp":1789564649878,"change":1.71,"changeRate":0.008465,"amplitude":0.010149},"postHourTrading":{"tag":"盘后","latestPrice":203.09,"preClose":202,"latestTime":"19:59 EDT","volume":3436,"amount":694324.56,"timestamp":1789516769053,"change":1.09,"changeRate":0.005396,"amplitude":0.005396},"volumeRatio":0.629158,"impliedVol":0.218,"impliedVolPercentile":0.2749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50950000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":0.629158,"shares":50950000,"dividePrice":0.404,"high":204.1599,"amplitude":0.010346,"preClose":202,"low":202.07,"week52Low":138.785,"pbRate":"1.27","psRate":"248.83","week52High":217.12,"institutionHeld":0,"latestPrice":202.99,"committee":0.68,"eps":6.311863,"divideRate":0.00199,"volume":239807,"delay":0,"ttmEps":6.311863,"open":202.49,"prevYearClose":168.77,"prevWeekClose":202.93,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":205.49,"twentyDayClose":203.56,"sixtyDayClose":177},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666309213","title":"安進-阿斯利康肺癌聯合用藥在後期臨床試驗中顯著提升生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309213","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309213?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 10:39","pubTimestamp":1788921579,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1023059063.AUD","IBBJ","IBBQ","AMGN","LU0889565916.HKD","BK4588","LU0320765992.SGD","IBB","LU0868494617.USD","LU0058720904.USD","PSYK","BK4139","PBE","BK4533","BIB","IE0002141913.USD","IE00B4R5TH58.HKD","LU1983299246.USD","IE0009355771.USD","BK4566","LU0109394709.USD","BK4581","SG9999001440.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2242646821.SGD","LU2468319806.SGD","PJP","LU1571399168.USD","TBXU","BBH","LU2242652126.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","BK4585","IE00B2B36J28.USD","MDTX","IE00BJJMRZ35.SGD","BK4599","LU2112291526.USD","LU0122379950.USD","BK4534","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112638879","title":"市場風向標：安進股價遭受重創","url":"https://stock-news.laohu8.com/highlight/detail?id=1112638879","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112638879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 05:35","pubTimestamp":1788903338,"startTime":"0","endTime":"0","summary":"“这对安进而言，堪称最糟糕的结局。”——巴克莱分析师艾米丽·菲尔德如此评价。此前，诺华制药公布了其心脏病药物令人失望的试验结果，这一披露不仅让诺华自身承压，更给安进旗下一款重磅药物蒙上了厚厚的阴影。","market":"us","thumbnail":"https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1023059063.AUD","LU0868494617.USD","PBE","LU1983299246.USD","IE00B4R5TH58.HKD","LU2112291526.USD","BK4534","IBBQ","LU0289739699.SGD","LU0320765992.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","AMGN","IE00BJJMRZ35.SGD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU2242646821.SGD","IBB","LU1057294990.SGD","IE0009355771.USD","BIB","IE0002141913.USD","LU2089984988.USD","PJP","BK4581","SG9999001440.SGD","BK4599","BBH","TBXU","BK4566","BK4533","LU2242652126.USD","BK4585","LU2468319806.SGD","LU0058720904.USD","LU1571399168.USD","LU0109394709.USD","LU0122379950.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136308873","title":"Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1136308873","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136308873?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897732,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前披露，其在海外市场具备资格获取最高达2.8亿美元的里程碑款项，外加相应特许权使用费收入。据悉，这家生物科技企业所预期的资金流入将源自美国以外地区。对Assembly Biosciences而言，这笔潜在收入不仅反映其管线资产的外部合作价值，也可能为其后续研发投入提供坚实支撑。市场人士认为，此类非美国市场的收益结构有助于分散地域风险，增强公司财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","LU0122379950.USD","LU0289739699.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU0109394709.USD","LU2087621335.USD","LU2112291526.USD","LU1061106388.HKD","SG9999015986.USD","IBB","LU0320765992.SGD","LU2468319806.SGD","BK4578","ASMB","BK4139","LU1585245621.USD","LU1674673691.USD","LU1023059063.AUD","IE00B19Z3581.USD","BK4550","BBH","BK4568","LU0114720955.EUR","LU1778281490.HKD","IE0002270589.USD","LU1066051498.USD","SG9999015978.USD","BIB","LU0965508806.USD","LU2089984988.USD","MEDI","TMED","LU1674673428.USD","IE00BKVL7J92.USD","LU0889565916.HKD","LU1839511570.USD","LU0058720904.USD","LU1571399168.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","TBXU","LU0965509010.AUD","LU1430594728.SGD","LU0234570918.USD","BK4585","LU1934455194.USD","LU1037948541.HKD","LU1037948897.HKD","LU1934455863.HKD","LU2357627491.SGD","SG9999015945.SGD","BK4532","LU1066053197.SGD","BK4583","IE00BSNM7G36.USD","GILD","LU0823416689.USD","LU0861579265.USD","BK4566","LU0965509101.SGD","LU0882574055.USD","BK4588","LU0965509283.SGD","IE00B3T34201.USD","IBBQ","IE00B7SZLL34.SGD","LU0859254822.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154623157","title":"Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623157","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154623157?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897731,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前宣布，其研发管线中的候选药物Gs-1179有望在2026年年底之前顺利迈入针对生殖器疱疹的二期临床试验阶段。生殖器疱疹作为一种常见的性传播感染疾病，全球患者群体庞大，对创新疗法的需求十分迫切。Assembly Biosciences正积极加速该药物的研发进程，以期尽早为患者带来新的治疗选择。业内分析人士指出，若Gs-1179能够顺利通过后续试验的严格考验，将可能重塑该适应症的市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","BK4139","LU0114720955.EUR","LU1057294990.SGD","LU1066051498.USD","LU0058720904.USD","LU1778281490.HKD","LU1674673691.USD","LU1037948541.HKD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1934455194.USD","LU1585245621.USD","BK4550","TBXU","LU2468319806.SGD","SG9999015978.USD","BK4585","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1571399168.USD","LU0965509010.AUD","LU1430594728.SGD","LU1066053197.SGD","BK4583","LU0109394709.USD","LU2357627491.SGD","LU0965509101.SGD","LU0320765992.SGD","BMED","SG9999015952.SGD","LU1674673428.USD","IE00BSNM7G36.USD","BK4588","GILD","TMED","IE00B3T34201.USD","LU0965508806.USD","IE0002270589.USD","MEDI","BIB","LU1061106388.HKD","LU0234570918.USD","IBBQ","LU2087621335.USD","BBH","LU0122379950.USD","ASMB","BK4566","LU0861579265.USD","LU1037948897.HKD","LU1839511570.USD","LU1934455277.USD","LU1934455863.HKD","BK4568","IE00B7SZLL34.SGD","LU0823416689.USD","LU2324357040.USD","BK4578","IBB","SG9999015986.USD","LU0965509283.SGD","LU2112291526.USD","BK4532","LU2089984988.USD","SG9999015945.SGD","LU0859254822.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115029168","title":"Assembly Biosciences：吉利德獨享HSV HPI項目臨床開發與商業化權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1115029168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115029168?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897702,"startTime":"0","endTime":"0","summary":"Assembly Biosciences宣布，吉利德科学已保留其HSV HPI项目的独家临床开发及商业化权利。这一决定标志着双方合作进一步深化，吉利德将全权主导该项目的后续推进与市场布局。对于Assembly Biosciences而言，此举不仅明确了合作伙伴的战略优先级，也为其自身聚焦其他管线资源提供了更大灵活性。业内观察人士指出，HSV HPI项目的独家授权，反映了吉利德在抗病毒治疗领域持续加码的雄心，同时也凸显了该类创新疗法在未被满足的医疗需求中所蕴含的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASMB","BK4583","LU2324357040.USD","LU0114720955.EUR","MEDI","SG9999015978.USD","LU1430594728.SGD","BIB","IE00B19Z3581.USD","LU1839511570.USD","GILD","LU2089984988.USD","LU1037948541.HKD","LU0965509101.SGD","LU0289739699.SGD","LU2112291526.USD","BK4566","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IBBQ","LU1037948897.HKD","BK4578","SG9999015986.USD","LU0965508806.USD","LU2468319806.SGD","LU2087621335.USD","LU2357627491.SGD","BK4139","LU1023059063.AUD","LU0320765992.SGD","LU0882574055.USD","LU1934455277.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU0122379950.USD","LU0234570918.USD","LU1778281490.HKD","BK4568","LU0889565916.HKD","LU0058720904.USD","LU1674673691.USD","BK4550","LU1061106388.HKD","LU1571399168.USD","BMED","LU1066053197.SGD","IE00B3T34201.USD","IE0002270589.USD","BBH","IE00BKVL7J92.USD","LU1934455863.HKD","BK4585","TBXU","TMED","IE00B19Z3B42.SGD","LU0965509283.SGD","LU0109394709.USD","LU0823416689.USD","LU1057294990.SGD","LU0859254822.USD","SG9999015945.SGD","BK4588","LU1674673428.USD","LU1934455194.USD","IBB","BK4532","LU0965509010.AUD","SG9999015952.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179230759","title":"Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權","url":"https://stock-news.laohu8.com/highlight/detail?id=1179230759","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179230759?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897669,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司已正式行使与吉利德科学就HSV解旋酶-引物酶抑制剂项目达成的美国利润分成选择权。这一战略举措标志着双方合作进入新阶段，有望加速该抗病毒疗法的临床开发与商业化进程。通过行使该选择权，Assembly Biosciences将能够分享该药物在美国市场的未来收益，同时借助吉利德在抗病毒领域的深厚积累与市场渠道，共同推进这一潜在重磅药物的落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1934455863.HKD","BK4566","BK4578","LU1066053197.SGD","LU1585245621.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU0320765992.SGD","BK4550","LU1674673691.USD","LU0861579265.USD","LU0882574055.USD","BK4532","IE00BSNM7G36.USD","LU1037948541.HKD","LU1037948897.HKD","LU1061106388.HKD","LU0114720955.EUR","BK4588","LU1430594728.SGD","TMED","LU2324357040.USD","SG9999015945.SGD","SG9999015986.USD","LU2357627491.SGD","IBBQ","LU0289739699.SGD","BIB","LU0058720904.USD","LU0109394709.USD","MEDI","ASMB","LU0965508806.USD","LU2112291526.USD","SG9999015952.SGD","BK4139","IE0002270589.USD","BK4568","SG9999015978.USD","BK4583","IE00BZ1G4Q59.USD","LU1778281490.HKD","IE00BKVL7J92.USD","LU0965509283.SGD","LU1934455194.USD","LU2087621335.USD","LU2089984988.USD","LU2468319806.SGD","LU1066051498.USD","IBB","LU0823416689.USD","LU1057294990.SGD","LU0965509101.SGD","BBH","LU1674673428.USD","IE00B7SZLL34.SGD","BK4585","LU0859254822.USD","LU1571399168.USD","LU1934455277.USD","LU0889565916.HKD","BMED","LU0234570918.USD","TBXU","GILD","LU0965509010.AUD","LU1839511570.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111756325","title":"安進股價或創二十餘年來最大單日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1111756325","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111756325?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:23","pubTimestamp":1788891793,"startTime":"0","endTime":"0","summary":"安进公司股价近期重挫逾9%，这一跌幅令这家生物技术巨头有望迎来自2000年10月以来最惨淡的单日表现。此番暴跌的导火索，源于诺华制药宣布其心脏病药物pelacarsen在降低心血管事件风险方面未能优于安慰剂，试验宣告失败。周二，礼来股价小幅下挫1.9%。安进的跌势因BMO资本市场的下调评级而进一步加剧，使其沦为标普500指数和纳斯达克100指数中的最大输家。","market":"us","thumbnail":"https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BBH","IE00B2B36J28.USD","AMGN","LU1061106388.HKD","LU0889565916.HKD","BK4566","LU0058720904.USD","04332","IE0009355771.USD","BK4588","IBB","LU0109394709.USD","LU0868494617.USD","BIB","LU1571399168.USD","LU1057294990.SGD","LU1023059063.AUD","LU2089984988.USD","PJP","LU2242652126.USD","LU2468319806.SGD","BK4534","TBXU","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242646821.SGD","PBE","BK4599","IBBQ","SG9999001440.SGD","BK4581","LU0122379950.USD","BK4533","BK4139","LU0320765992.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374214","title":"福泰製藥(VRTX)股票9月8日盤中下跌3.06%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374214","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374214?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:16","pubTimestamp":1788891392,"startTime":"0","endTime":"0","summary":"• Vertex 股价在反弹至接近52周高点后遭遇波动与获利回吐。\n• 对 Crinetics 的收购整合要到2029年才能实现非GAAP增盈。\n• 技术指标显示 MACD 呈中性，RSI 呈中性，威廉指标（Williams %R）呈超卖状态。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156640-market-movers-vrtx-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU2417539215.USD","SG9999013999.USD","LU2362541513.USD","BK4588","IE0002270589.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU1674673428.USD","LU1778281490.HKD","LU0234570918.USD","SG9999001176.USD","LU0079474960.USD","BK4585","LU0417517546.SGD","LU1035775433.USD","BK4532","IBB","LU1069344957.HKD","GNMX","PBE","LU0889565916.HKD","LU0432979614.USD","IDNA","BBH","IBBQ","SG9999001176.SGD","LU1674673691.USD","LU2362541273.HKD","LU1093756325.SGD","BIB","LU1430594728.SGD","BK4533","IE00BJT1NW94.SGD","LU0061475181.USD","IE00B2B36J28.USD","LU2362540622.SGD","SGXZ57979304.SGD","TBXU","LU0289739699.SGD","LU1585245621.USD","IE0002141913.USD","IE0009355771.USD","LU0256863811.USD","LU1093756168.USD","LU2237438978.USD","IE00B894F039.SGD","VRTX","BK4139","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374570","title":"吉利德科學(GILD)股票9月8日盤中下跌3.26%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374570","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374570?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 01:16","pubTimestamp":1788887780,"startTime":"0","endTime":"0","summary":"• 吉利德在经历了长达数月的持续上涨后，因获利回吐而出现回调。\n• 强劲的第二季度营收主要受其旗舰 HIV 和 Trodelvy 产品线的推动。\n• 分析师维持“买入”评级，平均目标价为 157.79 美元。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156554-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0965508806.USD","LU1674673691.USD","MEDI","LU1037948541.HKD","SG9999015986.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU1934455277.USD","BK4585","LU0114720955.EUR","LU2324357040.USD","IE00BZ1G4Q59.USD","TMED","LU0109394709.USD","GILD","IBBQ","LU1571399168.USD","BMED","TBXU","BK4583","SG9999015952.SGD","LU0058720904.USD","BK4568","BK4578","SG9999015978.USD","LU0289739699.SGD","LU0882574055.USD","IBB","LU0823416689.USD","BK4532","IE00B19Z3581.USD","LU1430594728.SGD","IE00B3T34201.USD","BIB","LU1839511570.USD","SG9999015945.SGD","LU2087621335.USD","LU2112291526.USD","LU0122379950.USD","LU0859254822.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0320765992.SGD","LU0965509101.SGD","LU1023059063.AUD","IE00B7SZLL34.SGD","LU1778281490.HKD","LU0861579265.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371445","title":"諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371445","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371445?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 00:41","pubTimestamp":1788885660,"startTime":"0","endTime":"0","summary":"——Royalty Pharma** RPRX重申“其2030年投资组合收入目标为47亿美元或更高”** 计入本交易日涨幅，该股今年以来累计上涨54.7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4501DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","AMGN","BK4585","IBBQ","BIB","RPRX","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","LU0058720904.USD","LU1057294990.SGD","BK4007","LU0320765992.SGD","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","IONS","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376637","title":"安進(AMGN)股票9月8日盤中下跌8.33%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376637","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376637?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 22:16","pubTimestamp":1788876978,"startTime":"0","endTime":"0","summary":"• 诺华 pelacarsen 试验失败，加大了安进竞品 olpasiran 的临床不确定性。\n• 出于对估值的担忧，BMO Capital 将安进的评级从“跑赢大盘”下调至“与大盘持平”。\n• 技术指标显示，安进的 RSI 为 40.256，威廉指标（Williams %R）为 97.857。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156239-market-movers-amgn-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","SG9999001440.SGD","LU2112291526.USD","LU1023059063.AUD","BIB","BBH","IBB","IE00B2B36J28.USD","LU0122379950.USD","BK4534","LU1061106388.HKD","LU2242652126.USD","PJP","BK4533","LU2089984988.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BK4581","TBXU","LU1057294990.SGD","LU2242646821.SGD","BK4588","LU0868494617.USD","IE00B4R5TH58.HKD","BK4585","LU0109394709.USD","LU1571399168.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","BK4566","AMGN","LU0289739699.SGD","IE0009355771.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4599","IBBQ","LU0889565916.HKD","LU1983299246.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月8日-周二开盘时，华尔街主要股指涨跌不一，中东地区新一轮冲突推动油价升至7月下旬以来的最高水平，而市场正在等待本周晚些时候","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","LU0011850046.USD","IONL","LU1989772923.USD","LU2362540622.SGD","BK4533","BK4597","LU1057294990.SGD","LU2506952097.USD","SGML","IE00BLSP4452.SGD","LU0170899867.USD","ICLN","LU0029874061.USD","LU0444973449.USD","LU1861558580.USD","LU0266013472.USD","PTH","SEI","WQTM","BK4585","IE00B19Z3B42.SGD","IE00BBT3K403.USD","PJP","IOYY","LU0138981039.USD","LU0868494617.USD","LU1861559042.SGD","BK4170","BEZ","LU1989771016.USD","LU0122379950.USD","LU0225284248.USD","SG9999003800.SGD","SGXZ57979304.SGD","SRPT","BK4581","LU1791710582.SGD","LU2242652126.USD","PFE","LU1303367103.USD","BEC","LU1815336760.USD","LU0225283273.USD","IE0009354923.USD","LU1791710400.SGD","HYDR","LU0889565916.HKD","LU2244417387.USD","IE00B66KJ199.SGD","BK4556","QTUP","BK4548","LU0058720904.USD","BK4602","IE00B19Z4B17.USD","LU0823417737.USD","BK4592","IE00B3T34201.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","ABM","LU2089984988.USD","WATS","MEDX","BK4120","CQTM","BK4591","BK4541","IE0031619046.USD","BK4121","IE0009355771.USD","LU0957808578.USD","SG9999011175.SGD","BK4124","LU0528227936.USD","PBE","SG9999001440.SGD","SMOG","LU1066053197.SGD","GNMX","BK4007","IE00B4R5TH58.HKD","LU1720051108.HKD","LU2506951792.HKD","LU0187121727.USD","LU1989764748.USD","LU0114720955.EUR","RGTU","IONZ","LU1291159041.SGD","BK4568","CNRG","LU2112291526.USD","LU2362541513.USD","IE00BLSP4239.USD","LU2506952170.USD","RGTI","SG9999002232.USD","TBXU","BE","BEX","LU0444971666.USD","LU1366192091.USD","IE0002141913.USD","IONS","LU2357125470.USD","LU0208291251.USD","LU0456855351.SGD","CHRW","LU1989764664.SGD","IE000M9KFDE8.USD","LU2242649171.HKD","BEG","LU0353189763.USD","LU0345769631.USD","LU1894683264.USD","IBBQ","LU0109394709.USD","EGGY","LU0823414478.USD","OIH","IE0002270589.USD","LU1894683348.USD","IE00B2B36J28.USD","04332","LU1548497426.USD","LU1804176565.USD","LU1988902786.USD","LU0070302665.USD","BK4532","LU0878866978.SGD","LU2468319806.SGD","LU2294711713.HKD","LU1642822529.SGD","LU2543165471.USD","LU2596442595.SGD","ZAP","UPGR","BK4534","LU0950375773.USD","BK4504","LU0433182093.SGD","IBB","SG9999013999.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","IONQ","BK4139","LU0823416689.USD","BK4535","LU2087625088.SGD","IONX","LU0882574055.USD","PHVS","LU0267386448.USD","GNOM","BSX","LU1571399168.USD","LU1983299246.USD","SG9999001176.USD","LU2264538146.SGD","LU2098885051.SGD","LU0432979614.USD","LU1153585028.USD","LU0823414551.USD","LU1093756325.SGD","BBH","BK4182","LU0321505439.SGD","LU1023059063.AUD","RGYY","VCLN","LU0068578508.USD","LU0823417653.USD","LU1093756168.USD","BK4550","LU2265009873.SGD","LU2242646821.SGD","BK4505","CTEC","LU1883839398.USD","RGTZ","LU2324357040.USD","LU0306806265.USD","UNFI","BK4168","LU0345769128.USD","LU0128526141.USD","DYN","LU0306807586.USD","BK4082","AMGN","LU2491049909.HKD","VTWG","IE00B19Z3581.USD","ALV","SRPU","LU1064131342.USD","BK4567","IONC","ILMN","IE0034235188.USD","LU0320765489.SGD","BIB","BK4179","LU0048584097.USD","LU2506951958.HKD","LU2491050071.SGD","LU0353189680.USD","LU2491050154.USD","LU2249611893.SGD","NVS","RGTX","BK4141","BK4588","IE00BFTCPJ56.SGD","LU0238689110.USD","ROIV","RGTC","LU1061106388.HKD","LU0234572021.USD","SHAK","LU0985481810.HKD","LU0289739699.SGD","LU1489326972.SGD","BK4209","BK4131","LU2362541273.HKD","SG9999001176.SGD","LU0320765992.SGD","SIMS","BHVN","IBAT","LU0077335932.USD","LU0251132253.USD","LU0476273544.USD","LU1718418525.SGD","LU2357305700.SGD","BK4578","SG9999002224.SGD","LU0211331839.USD","LU2506951875.HKD","NTLA","OZEM","USNG","BK4599","LU0321505868.SGD","PPH","XES","BK4566","LU1989772840.SGD","BK4102","FRNW","LU0225771236.USD","LU1878469433.USD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665251375","title":"更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=2665251375","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665251375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:52","pubTimestamp":1788875520,"startTime":"0","endTime":"0","summary":"更新版 1-阿斯利康的联合用药方案在晚期研究中帮助肺癌患者延长了生存期全文补充了有关临床试验和背景的详细信息路透9月8日-阿斯利康AZN.L周二表示，其抗癌药物Imfinzi与安进的AMGN.O靶向免疫疗法Imdelltra联合使用，在一项晚期临床试验中显著提高了广泛期小细胞肺癌患者的总生存期。癌症治疗药物占阿斯利康销售额近一半；2025年，在该公司256.2亿美元的肿瘤产品收入中，Imfinzi贡献了60.6亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T45013T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU2468319806.SGD","BK4585","LU0997586432.USD","LU1196032939.SGD","PJP","LU0823416689.USD","IE00B3T34201.USD","LU2108987350.USD","LU0029864427.USD","LU0557290698.USD","IE0009355771.USD","AMGN","LU1267930227.SGD","LU0738911758.USD","BK4533","LU0289739699.SGD","IBB","LU0889566641.SGD","LU1153585028.USD","LU2089284900.SGD","LU2237443622.USD","LU0171293334.USD","BK4588","TBXU","LU0211327993.USD","LU0708994859.HKD","LU0969580561.USD","BBH","LU0211328371.USD","PBE","LU0553294199.USD","LU1273509221.SGD","LU1267930490.SGD","LU0158827948.USD","LU0784384876.USD","LU2237443382.USD","LU2242646821.SGD","AZN.UK","LU2125909593.SGD","LU1046234339.USD","03165","LU0211326755.USD","LU0792757196.USD","LU1267930813.SGD","LU2279689827.SGD","IBBQ","LU0058720904.USD","LU0887340254.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375527","title":"安進股價下跌7%，創下自2025年6月以來最大單日跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:30","pubTimestamp":1788874246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJT1NW94.SGD","LU2468319806.SGD","BK4566","BBH","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4534","SG9999001440.SGD","BK4139","BK4533","IBBQ","TBXU","IE00B2B36J28.USD","IE0002141913.USD","LU0122379950.USD","LU1023059063.AUD","BK4599","LU0889565916.HKD","LU2242646821.SGD","BIB","LU0868494617.USD","BK4581","PBE","LU2112291526.USD","LU1061106388.HKD","LU0058720904.USD","BK4588","AMGN","BK4585","LU1057294990.SGD","IBB","LU2242652126.USD","LU1983299246.USD","LU0320765992.SGD","LU0289739699.SGD","LU2089984988.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665732793","title":"更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665732793","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665732793?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:14","pubTimestamp":1788873260,"startTime":"0","endTime":"0","summary":"阿斯利康抗癌药物组合在晚期临床试验中达到主要生存目标路透9月8日-阿斯利康（AstraZeneca）AZN.L周二表示，其抗癌药物Imfinzi与安进（Amgen）的AMGN.O靶向免疫疗法Imdelltra联合使用，在一项晚期临床试验中，显著提高了广泛期小细胞肺癌一线治疗患者的总生存期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S450114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0969580561.USD","LU1023059063.AUD","BK4599","LU2355687059.USD","LU1481599808.USD","LU0077335932.USD","AMGN","LU0526926950.USD","LU1923622614.USD","LU0289739699.SGD","LU0997586515.USD","LU0109394709.USD","LU1003076772.USD","LU0545039389.USD","LU0661504455.SGD","LU0827474353.SGD","LU1061106388.HKD","LU1863844749.USD","LU0957799991.USD","LU1829250122.USD","LU2242652126.USD","BK4139","LU0889566641.SGD","LU2433249047.HKD","LU2279689827.SGD","IE0034235188.USD","LU2091194634.USD","LU1487256676.USD","AZN.UK","IBBQ","LU0058720904.USD","LU0882574055.USD","BBH","LU0203347892.USD","LU1046234339.USD","PJP","LU0784383803.USD","LU0868494617.USD","IBB","LU1084165304.USD","LU0122379950.USD","LU2237443465.HKD","LU1880407132.USD","LU0029864427.USD","LU0920783379.SGD","PBE","BIB","03165","TBXU","LU1170363599.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115495471","title":"安進Phase 3 Dellphi-305研究重大突破：總生存期獲益顯著優於度伐利尤單抗單藥治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1115495471","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115495471?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:07","pubTimestamp":1788872830,"startTime":"0","endTime":"0","summary":"安进公司宣布，其Phase 3 Dellphi-305临床研究取得重大成果——与度伐利尤单抗单独用药相比，该疗法在总生存期上展现出显著且具有临床意义的改善。这一里程碑式的发现，无疑为肿瘤治疗领域注入了新的活力与希望。尽管完整的详细数据尚未全面披露，但安进方面表示，其临床意义及安全性特征将在即将召开的重大学术会议上进行详尽报告。安进公司并未止步于此。随着研发管线的持续推进，安进正逐步兑现其以创新疗法攻克严重疾病的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IE00BJT1NW94.SGD","PBE","TBXU","BK4566","LU0868494617.USD","LU2242652126.USD","IE00B4R5TH58.HKD","BK4534","IE00BFTCPJ56.SGD","LU1571399168.USD","BK4533","IE00BJJMRZ35.SGD","PJP","IE0009355771.USD","LU0320765992.SGD","BK4585","LU0109394709.USD","LU2112291526.USD","BK4581","LU0122379950.USD","IE0002141913.USD","BIB","BBH","LU1057294990.SGD","LU0889565916.HKD","IE00B2B36J28.USD","LU0289739699.SGD","LU0058720904.USD","SG9999001440.SGD","LU1983299246.USD","BK4599","LU2089984988.USD","BK4139","LU1023059063.AUD","AMGN","IBB","LU1061106388.HKD","LU2468319806.SGD","BK4588","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109517247","title":"Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1109517247","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109517247?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:04","pubTimestamp":1788872687,"startTime":"0","endTime":"0","summary":"Imdelltra®与Imfinzi®的联合疗法，于一线广泛期小细胞肺癌治疗领域，取得了具有划时代意义的总生存期提升。这一突破性进展，不仅为患者带来了新的曙光，也重塑了该领域的治疗格局。从数据层面观察，联合治疗方案的生存获益尤为显著，堪称里程碑式的成就。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU2242652126.USD","PJP","BK4533","LU1061106388.HKD","BK4139","LU0289739699.SGD","LU0122379950.USD","TBXU","SG9999001440.SGD","AMGN","BK4588","IE00BJJMRZ35.SGD","LU0058720904.USD","IE0009355771.USD","BK4534","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IBB","LU0889565916.HKD","BK4581","LU2112291526.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4566","BK4585","BIB","LU0109394709.USD","IBBQ","BK4599","BBH","LU2468319806.SGD","LU2089984988.USD","IE0002141913.USD","LU0868494617.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387373","title":"BMO下調安進及BioNTech評級至「與大市同步」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:59","pubTimestamp":1788872377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIB","LU1057294990.SGD","PBE","LU1571399168.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2089984988.USD","AMGN","LU2242652126.USD","BK4139","LU2468319806.SGD","LU1023059063.AUD","LU2112291526.USD","BK4585","IBB","PJP","LU1983299246.USD","LU0289739699.SGD","BBH","LU0058720904.USD","BK4566","IE0002141913.USD","TBXU","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2242646821.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4581","BK4599","BK4588","SG9999001440.SGD","LU0868494617.USD","LU0122379950.USD","BK4534","IBBQ","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332998","title":"美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103332998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%，报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备，并与ASML签订光罩尺寸升级合作协议，助力降低AI芯片制造成本。","market":"uk","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU0154245673.USD","IE00B7SZLL34.SGD","LU0211326755.USD","LU2360108059.USD","SG9999014567.USD","LU2491049909.HKD","IE00BSNM7G36.USD","BK4608","LU0630314457.HKD","INT","IE00B5TLWC47.USD","LU1323610961.USD","NVS","IE000M9KFDE8.USD","LU0345780950.USD","IE000SO60NU8.SGD","LU1582987324.SGD","LU1267930490.SGD","LU2092937221.SGD","LU1642822529.SGD","LU0823414478.USD","LU1883866441.USD","EMM","TEXU","LU0251142724.SGD","SG9999014542.SGD","LU2237957902.USD","PXI","TINS","BGIA","IE00B19Z3581.USD","LU1929549753.HKD","IE00B66KJ199.SGD","LU0266512473.USD","SG9999001440.SGD","LU1691799644.USD","LU1974910355.USD","BK4612","LU0889565916.HKD","LU0792757196.USD","IE0031619046.USD","LU1074936037.SGD","LU0719512351.SGD","LU1718418525.SGD","DDM","LU0077335932.USD","IE00BLSP4239.USD","BK4538","LU2506952170.USD","LU2108987350.USD","LU0130517989.USD","LU1150488135.SGD","LU0203345920.USD","FTXN","IE000F7OJYX1.SGD","LU1823568750.SGD","LU2473716301.USD","LU2462591277.SGD","ASIA","IE000MB6IJN5.SGD","IE00BD6J9T35.USD","ORCU","LU0072462343.USD","LU0541501648.USD","LU2211814178.USD","LU0345770308.USD","LU0882574055.USD","LU1791710400.SGD","LU0321505439.SGD","LU2764263039.SGD","LU1839511570.USD","BK4141","LU0541502299.USD","SG9999001424.SGD","LU2237443382.USD","LU1162221912.USD","OILT","LU0274383776.USD","BK4534","DOG","BK4157","LU0359201885.HKD","LU0256863811.USD","LU0052756011.USD","LU0976567544.SGD","EFA","LU0787776722.HKD","LU2023250504.SGD","LU1585245621.USD","LU1868837565.USD","LU0082616367.USD","03165","LU1935042215.USD","LU2458330169.SGD","SG9999015341.SGD","BK4566","LU0323591593.USD","LU0266512127.USD","LU0157215616.USD","LU1235294995.USD","LU2087621335.USD","LU0053666078.USD","LU0965509283.SGD","LU1989772923.USD","BK7104","ORCS","LU0162691827.USD","LU0661504455.SGD","LU2102340556.USD","LU2326559502.SGD","LU2860962120.EUR","BK4148","SGXZ81514606.USD","BAI","LU1734074674.USD","LU0353189763.USD","LU1732799900.SGD","LU2471134952.CNY","LU1992135399.USD","LU1988902786.USD","LU0048584097.USD","FDTX","LU0234572021.USD","LU0823038988.USD","IE00BWXC8680.SGD","LU0143863784.USD","LU2237443549.SGD","IE00B1XK9C88.USD","LU2764262908.HKD","UDOW","BK4201","LU0251131958.USD","LU2362541513.USD","BK4528","SG9999015358.SGD","BLOX","LU2750360641.GBP","KNOW","XLE","ORCL","LU0823414551.USD","LU1861215975.USD","PPH","LU2491050154.USD","LU2750360997.AUD","LU1430597077.USD","IE0009355771.USD","LU1064131342.USD","LU2498475776.HKD","LU0345769631.USD","LU1778281490.HKD","LU2458330243.SGD","LU0431992006.USD","PXE","LU1066051498.USD","IFLR","LU0154236417.USD","TEK","FOTO","IE00BZ199S13.USD","LU0823417653.USD","SG9999002232.USD","LU0553294199.USD","LU2290526834.HKD","QTUP","BK4504","GNMX","ADVE","LU0384037296.USD","INTW","LU1861220033.SGD","IE0004091025.USD","VDE","LU0251132253.USD","LU0094547139.USD","LU0345774391.USD","BK4213","LU1815336760.USD","IE00BJJMRZ35.SGD","LU0795875169.SGD","LU1989771016.USD","LU0742534661.SGD","LU2746668974.SGD","LU1153585028.USD","BK4139","LU2430703095.HKD","LU0061474960.USD","LU1267930227.SGD","LU2272731600.USD","LU1917777945.USD","TDIV","CWI","LU2237957811.SGD","LU2487616109.SGD","QQQA","CNEQ","FCG","LU0648001328.SGD","LU0211327993.USD","LU0138981039.USD","LU0861579265.USD","IE0002270589.USD","BK4505","LU2028103732.USD","LU0950375773.USD","LU1267930813.SGD","LU0466842654.USD","SDOW","LU2999663052.SGD","TBXU","LU2362541273.HKD","LU0122376428.USD","LU1003077747.HKD","LU0114720955.EUR","LU0143551892.USD","BK4082","LU2663582299.SGD","LU2360106780.USD","IGV","LU2125154935.USD","LU0143863198.USD","CRAK","LU2592432038.USD","OGIG","BK4548","LU0124676726.USD","BK4535","BK4550","SG9999001176.SGD","TTEQ","LU1934455863.HKD","LU0823421333.USD","LU0289960550.SGD","LU1282649067.USD","LU2265009873.SGD","PQNT","BIB","IE00BQXX3F31.USD","LU0417517546.SGD","BK4602","IE00BMPRXR70.SGD","LU1061106388.HKD","LU2237443978.SGD","LU0149725797.USD","WEEI","LU0211331839.USD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU0203347892.USD","GXPE","LU0098860793.USD","LU0612318385.USD","LU1815333072.USD","BK4516","LU0949170772.SGD","LU2089984988.USD","LU0432979614.USD","RSPG","BK4605","IE00BKDWB100.SGD","LU1282649810.SGD","LU1983299246.USD","BK4570","LU1037948541.HKD","LU0889566641.SGD","LU0267386448.USD","LU1508157978.USD","LU0320765489.SGD","LU2506951792.HKD","LU0321505868.SGD","LU0058720904.USD","LU1935043023.USD","IE00B775SV38.USD","LU2211815571.USD","AIS","IBBQ","LU2471134879.HKD","LU0234570918.USD","LEGR","CGDG","IE00B3S45H60.SGD","LU2505996681.GBP","LU2357627491.SGD","IE00B19Z4B17.USD","LU1548497426.USD","LU0957791311.USD","LU1804176565.USD","LU2505996509.AUD","LU1720051108.HKD","LU1712237335.SGD","LU0320765992.SGD","LU2324357040.USD","LU1935043536.SGD","FENY","LU0211326839.USD","LU0738911758.USD","PJP","LU0823434583.USD","LU1093756168.USD","LU1852331112.SGD","LU0081259029.USD","LU0788109394.HKD","IE00BQXX3C00.GBP","BK4599","SG9999014575.USD","LU0068578508.USD","LU0314106906.USD","LU0130103400.USD","BK4515","DIG","LU0256331488.USD","LU1935042488.USD","LU0433182093.SGD","IE00BHPRN162.USD","CTEX","LU2236285917.USD","IE00BZ1G4Q59.USD","ORCZ","BK4588","IE0034235303.USD","LU0187121727.USD","LU0980610538.SGD","SG9999000418.SGD","LU0942090050.USD","LU1430594728.SGD","IXC","EGGY","CGNG","WQTM","LU1150488218.USD","LU0210536198.USD","LU0109394709.USD","LU2471134523.USD","BK4533","BK4581","LU0266013472.USD","OZEM","LU2362540622.SGD","IE0004445239.USD","LU1582987597.SGD","BK4591","ORAC","LU1791710582.SGD","LU2931357623.SGD","SOXX","CHPS","LU0444971666.USD","IE00B2B36J28.USD","EPAI","TNGY","BK4138","LU2249611893.SGD","IE00BFXG1179.USD","LUMA","LU0070217475.USD","LU1934455194.USD","BK4543","LU0029874061.USD","LU1201861249.SGD","LU1674673428.USD","LU0310800965.SGD","SG9999003800.SGD","LU0345770993.USD","IYE","BK4526","LU2506952097.USD","IE00BYQQ9H92.USD","AVSE","LU1046421795.USD","BK4170","LU2430703251.USD","BK4578","LU1582986433.USD","LU1894683348.USD","LU0011850046.USD","IE00BKVL7J92.USD","LU2237443622.USD","LU2054465674.USD","LU0211328371.USD","LU2063271972.USD","LU0878004406.USD","LU1506573853.SGD","LU2506951958.HKD","LU0868494708.USD","BK4585","FTXL","IGE","LU2272731865.HKD","LU2764263203.CNY","LU2264538146.SGD","LU0823417737.USD","IE00BFXG0V08.USD","BK4559","CGGO","MEDX","CNAV","LU2462611646.USD","LU0859254822.USD","LU2357305700.SGD","IE00B1BXHZ80.USD","SG9999014559.SGD","SPTE","BK4579","LU2298321311.HKD","LU0985489474.SGD","SG9999011175.SGD","LU1720051017.SGD","LU0642271901.SGD","DXD","LU0300736492.USD","LU0289739699.SGD","IE00BQXX3D17.EUR","IE00BJT1NW94.SGD","LU2111349929.HKD","SG9999004220.SGD","CQTM","LU2491050071.SGD","LU2347655156.SGD","LU1623119135.USD","LU0316494557.USD","LU1435385759.SGD","BK4097","LU1066053197.SGD","DBEU","LU0158827948.USD","ORCX","LU0965509101.SGD","LU0477156953.USD","BK7095","LU0912757837.SGD","LU0528227936.USD","LU1048588211.SGD","LU0345781412.USD","LU2125154778.USD","LU0648000940.SGD","LU0878005551.USD","LU2089283258.USD","LU0198837287.USD","LU2471134796.USD","IE0002141913.USD","IE00B5949003.HKD","BK4512","LU0359202008.SGD","THNR","LU2129689514.USD","IE00BKPKM429.USD","BK4575","SGXZ99366536.SGD","ESIM","LU2954938101.SGD","PBE","LU2430703178.SGD","03145","IE00B4R5TH58.HKD","ASMH","BK4527","BK4592","LU0056508442.USD","LU0170899867.USD","LU0965508806.USD","TRUN","LU0072461881.USD","LU0823416689.USD","LU2242649171.HKD","ERX","IE00BGHQF524.EUR","LU0823434740.USD","LU0130102774.USD","LU0320765646.SGD","LU2360107168.USD","LU0084288322.USD","IE00BMPRXN33.USD","LU2133065610.SGD","LU0070302665.USD","LU0208291251.USD","CHPX","LU2720916845.USD","LU1992135472.HKD","LU0225283273.USD","IE000WAW04H5.SGD","LU0368265418.SGD","CGIC","LU2360032135.SGD","LU0128525689.USD","BK5113","LU2322448957.HKD","LU1366192091.USD","LU1093756325.SGD","SPRX","LU0612318971.USD","LU1316542783.SGD",".DJI","LU1989764664.SGD","LINT","LU0476273544.USD","LU1582986359.USD","LU2129689605.HKD","LU2242652126.USD","LU0154245756.USD","LU1057294990.SGD","LU0795875086.SGD","LU0654597011.USD","DBEF","LU1989772840.SGD","AVXC","DRIV","IE00B19Z3B42.SGD","BK4503","BK4529","LU0345769128.USD","LU2746668461.USD","LU0572939691.SGD","LU1571399168.USD","LU1989764748.USD","BK4007","DIA","LU2357125470.USD","IEO","LU0310799852.SGD","LU1201861165.SGD","LU0359201612.USD","LU2023251221.USD","LU0823039010.USD","LU1868837722.USD","LU0488056044.USD","CHAT","AIQ","LU2543165471.USD","LU0128526141.USD","LU1023057109.AUD","LU1934455277.USD","MEMX","LU1674673691.USD","LU0882747503.HKD","GNOM","SMH","LU0965509010.AUD","LU0823421416.USD","IEFA","LU0175139822.USD","LU2506951875.HKD","LU0444973449.USD","BK4554","LU1732800096.USD","LU0097036916.USD","IE00BBT3K403.USD","SG9999002521.SGD","LU0122379950.USD","HK0000304805.HKD","LU0345774631.USD","LU2250418816.HKD","LU0957808578.USD","LU2322448791.USD","LU0545039389.USD","IE000BZT7R73.USD","SPWO","LU2602419157.SGD","IE00BN8TJ469.HKD","LU0278409577.USD","LU1366333091.USD","LU1803068979.SGD","LU0238689110.USD","LU1035773651.USD","LU0048573561.USD","IE0004086264.USD","GSID","LU0878866978.SGD","BK4532","HYDR","LU0868486357.SGD","FENI","LU1935042991.SGD","LU0158827781.USD","INTC","LU0889565833.HKD","LU2272731782.SGD","LU0868494617.USD","LU1894683264.USD","FFGX","SGXZ57979304.SGD","LU0689626769.HKD","HK0000304797.USD","LU0683600562.USD","AVEM","IE00B3M56506.USD","DRLL","LU0264606111.USD","LU2041044095.USD","LU2271345857.HKD","LU2242646821.SGD","LU2089284900.SGD","UMMA","BK4023","IE00B7SZL793.SGD","IE00BMPRXQ63.HKD","LU2244417387.USD","LU2087625088.SGD","IE0009356076.USD","SPY","LU2468319806.SGD","XNTK","BK4147","LU1211504680.USD","LU0496365809.HKD","SGXZ51526630.SGD","IE0000B7K699.USD","LU1429558221.USD","IBB","HBMX","IE00B2Q91V27.USD","LU2089985449.USD","IE00BLSP4452.SGD","LU1489326972.SGD","LU0456854461.SGD","LU0210528500.USD","LU0353189680.USD","INYY","SG9999001176.USD","LU2294711713.HKD","LU1868838027.USD","LU2112291526.USD","LU2896262040.SGD","EMC","IE00B3CCJ963.GBP","LU0300736062.USD","LU2247934214.USD","LU1023059063.AUD","LU2106854487.HKD","LU2148611432.USD","ILOW","LU1291159041.SGD","LU0348723411.USD","WUGI","SG9999002224.SGD","BK4121","LU1037948897.HKD","LU1069347547.HKD","LU0572940350.SGD","CORO","LU0109392836.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665215326","title":"諾華試驗受挫且BMO下調評級，安進股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2665215326","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665215326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859661,"startTime":"0","endTime":"0","summary":"BUZZ-诺华试验受挫且BMO下调评级，安进股价下跌9月8日-** 安进公司（AMGN.O）股价盘前下跌4.8%，至416美元** 诺华公司（NOVN.S）的降胆固醇药物在一项备受关注的研究中未能达标，这引发了市场对安进公司（Amgen）实验性降胆固醇药物olpasiran的担忧 (link)** 摩根大通分析师表示，诺华的pelacarsen研究结果降低了市场对安进olpasiran的预期，而该","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","BK4534","IE0002141913.USD","BK4533","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","BK4599","LU0868494617.USD","SG9999001440.SGD","TBXU","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IBBQ","LU0889565916.HKD","LU0122379950.USD","LU0109394709.USD","LU1023059063.AUD","LU0320765992.SGD","IBB","PBE","BK4588","BK4581","LU2089984988.USD","IE00B2B36J28.USD","BK4566","PJP","BBH","LU1057294990.SGD","LU0289739699.SGD","LU2468319806.SGD","AMGN","LU1571399168.USD","LU2242646821.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BIB","LU1061106388.HKD","BK4585","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}